Disclaimer
Statements & Policies
Summary of Disclosures
PharmaStocksToday is a wholly owned subsidiary of PharmaStocksToday.com (hereinafter referred to as “IRPub,” “we,” “us,” or “our”). By accessing PharmaStocksToday (hereinafter referred to as “PharmaStocksToday,” “we,” “us,” or “our”) website you are representing affirmatively that you have read and understood the entirety of the following Statements & Policies, which include important information not included in this Summary of Disclosures (Summary). You represent affirmatively that you are not relying solely on this Summary.
By accessing the PharmaStocksToday website, you agree that you have reviewed and agree to the following Statements & Policies. THIS WILL CREATE A BINDING CONTRACT BETWEEN YOU AND PharmaStocksToday RELATIVE TO YOUR USE OF OUR WEBSITE, THE SERVICES WE THEREBY RENDER TO YOU, AND OUR USE OF THE INFORMATION YOU PROVIDE TO US. If you do not agree to these Statements & Policies, you may not use the PharmaStocksToday website and affirmatively acknowledge that you have not used or viewed content on the PharmaStocksToday website.
PharmaStocksToday provides readers with information regarding publicly traded companies that have paid a fee to PharmaStocksToday to provide advertising, news and public relations services on their behalf. PharmaStocksToday receives compensation from the companies in the form of cash and/or securities in the companies.
PharmaStocksToday is neither an investment adviser nor a broker-dealer. The information presented in the PharmaStocksToday website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. None of the information provided through this website constitutes advice or a recommendation. Please consult with an independent investment adviser or other financial adviser or financial professional before making an investment decision.
The opinions and analyses included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith. PharmaStocksToday makes no representation or warranty, expressed, implied, or statutory, is made as to the accuracy or completeness of such information, which may be subject to change without notice.
PharmaStocksToday and its owners, members, officers, directors and affiliates may own, or may buy and sell, securities of companies profiled on the PharmaStocksToday website at any time before, during, or after distribution of information on the companies by PharmaStocksToday.
By accessing PharmaStocksToday Holdings LLC (hereinafter referred to as “PharmaStocksToday,” “we,” “us,” or “our”) website you are representing affirmatively that you have read and understood the entirety of the following Statements & Policies, which include important information not included in this Summary of Disclosures (Summary). You represent affirmatively that you are not relying solely on this Summary. By accessing the PharmaStocksToday website, you agree that you have reviewed and agree to the following Statements & Policies. THIS WILL CREATE A BINDING CONTRACT BETWEEN YOU AND PharmaStocksToday RELATIVE TO YOUR USE OF OUR WEBSITE, THE SERVICES WE THEREBY RENDER TO YOU, AND OUR USE OF THE INFORMATION YOU PROVIDE TO US. If you do not agree to these Statements & Policies, you may not use the PharmaStocksToday website and affirmatively acknowledge that you have not used or viewed content on the PharmaStocksToday website.
PharmaStocksToday provides readers with information regarding publicly traded companies that have paid a fee to PharmaStocksToday to provide advertising, news and public relations services on their behalf. PharmaStocksToday receives compensation from the companies in the form of cash and/or securities in the companies.
PharmaStocksToday is neither an investment adviser nor a broker-dealer. The information presented in the PharmaStocksToday website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. None of the information provided through this website constitutes advice or a recommendation. Please consult with an independent investment adviser or other financial adviser or financial professional before making an investment decision. The opinions and analyses included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith. PharmaStocksToday makes no representation or warranty, expressed, implied, or statutory, is made as to the accuracy or completeness of such information, which may be subject to change without notice. PharmaStocksToday and its owners, members, officers, directors and affiliates may own, or may buy and sell, securities of companies profiled on the PharmaStocksToday website at any time before, during, or after distribution of information on the companies by PharmaStocksToday.
Safe Harbor Statement
This website includes forward-looking statements pertaining to future anticipated plans, performance and development of the companies on whose behalf we disseminate information. Any statements on this website that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” “intends,” or other words or phrases of similar import. Similarly, statements in this website that describe a company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward–looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
Copyright Notice
PharmaStocksToday owns and controls all rights, including copyright, in the content of the PharmaStocksToday website.
In accessing the PharmaStocksToday website, you agree that you may only download and/or view the content for your own personal, non-commercial use, and such content you agree expressly cannot be used in any pleading or for any purpose in a court of law, arbitration forum or adjudicatory proceeding.
Except where expressly stated otherwise, without the prior written permission of PharmaStocksToday, you are not permitted to copy, broadcast, download, store (in any medium), transmit, show or play in public, adapt or change in any way the content of the PharmaStocksToday website for any other purpose whatsoever.
Disclaimer
Neither PharmaStocksToday nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PharmaStocksToday website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PharmaStocksToday website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PharmaStocksToday website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.
The opinions and analysis included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith. PharmaStocksToday makes no representation or warranty, expressed, implied, or statutory, as to the accuracy or completeness of such information, which may be subject to change without notice. PharmaStocksToday shall not be liable for any errors or any actions taken in reliance thereon. Statements of opinion and belief are those of the authors and/or editors who contribute to this website, and are based solely upon the information possessed by such authors and/or editors. No inference should be drawn that PharmaStocksToday or such authors or editors have any special or greater knowledge about the companies profiled or any particular expertise in the industries or markets in which the profiled companies operate and compete.
Factual information on this website is obtained from public filings and other sources deemed to be reliable; however, PharmaStocksToday takes no responsibility for verifying the accuracy of such information and makes no representation that such information is accurate or complete. Certain statements included in this website may be forward-looking statements based on current expectations. PharmaStocksToday makes no representation and provides no assurance or guaranty that such forward-looking statements will prove to be accurate. Persons using the PharmaStocksToday website are urged to consult with independent financial advisers with respect to an investment in any company profiled herein. Additionally, persons using this website expressly represent that the content in this website is not and will not be a consideration in such persons’ investment decisions. Investors should verify independently information provided in the PharmaStocksToday website by completing their own due diligence on any company in which they are contemplating an investment and review a complete information package on that company, which should include, but not be limited to, the company’s annual reports, quarterly reports, press releases, and regulatory filings, which are available at no cost at the SEC’s website (sec.gov) or directly from the issuer.
Past performance of profiled securities is not indicative of future results. Companies profiled on this site may lack an active trading market for their securities and investing in securities that lack an active trading market or trade on certain media, platforms and markets are deemed highly speculative and carry a high degree of risk. Anyone investing in such companies should be able financially and prepared to bear the risk of loss and actual loss of his or her entire investment. The information on this website is not designed to be used as a basis for an investment decision. Instead, the purpose of this website is to enable issuers to establish visibility and become known or better known. Persons using the PharmaStocksToday website should confirm to their own satisfaction the veracity of any information prior to entering into any investment. The decision to buy or sell any security of a company that may be featured by PharmaStocksToday is done purely and entirely at the reader’s own risk. As a reader and user of this website, you agree that under no circumstances will you seek to hold liable PharmaStocksToday’s owners, members, officers, directors, partners, consultants or other persons involved in the publication of this website for any losses incurred by the use of information contained in this website.
PharmaStocksToday and its owners, members, officers, directors, contractors and affiliates may own, or may buy and sell, securities of companies profiled in this website at any time before, during, or after distribution of information on the companies by PharmaStocksToday. PharmaStocksToday and its contractors and affiliates may profit in the event the shares of the companies increase or decrease in value. Such securities may be bought or sold from time to time, even after PharmaStocksToday has distributed positive information regarding the companies. PharmaStocksToday does not guarantee that it will purchase the securities of profiled companies. PharmaStocksToday does not request from and does not require that PharmaStocksToday’s independent contractor writers and editors provide information to PharmaStocksToday about their trading activities, including trading activities about which they may wrote. PharmaStocksToday has no obligation to inform readers of its trading activities or the trading activities of any of its owners, members, officers, directors, contractors and affiliates and/or any companies affiliated with PharmaStocksToday’s owners, members, officers, directors, contractors and affiliates. PharmaStocksToday and affiliates may from time to time enter into agreements to purchase securities of publicly traded companies to provide financing to these companies.
Risk Warnings
The content published on this website is intended for and only to be used for reference purposes and is neither an offer nor a solicitation to purchase or sell any security or instrument or to participate in any particular trading strategy. None of the information provided through this website constitutes advice or a recommendation that any investment or trading strategy is suitable for any person. Further, users of this website agree that they are not using any content of this website in or in connection with an investment decision. Persons should consult with their financial advisers before making any investment decisions.
THERE CAN BE NO ASSURANCE THAT THE CONTENT PUBLISHED ON THIS SITE IS ACCURATE OR WITHOUT ERROR. ANY PERSON WHO MAKES USE OF SUCH CONTENT EXPRESSLY ASSUMES ALL RISKS FROM USING THE CONTENT. In particular, PharmaStocksToday does not guarantee it reviews, and is not responsible for confirming, the accuracy of issuer documents and information submitted for inclusion on this site. The issuer and its management are primarily responsible for the accuracy of any information regarding the issuer provided on this site. The issuers are the publishers of all information provided by the issuers available on this site. INVESTORS ARE STRONGLY ADVISED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM THIS SITE PRIOR TO MAKING ANY INVESTMENT DECISION.
OTC Risk Warnings
Because many securities traded Over-The-Counter (OTC) are relatively illiquid, or “thinly traded,” which tends to increase volatility in market prices, an investment in an OTC security involves a high degree of risk. These speculative and illiquid securities are often difficult for investors to buy or sell without significantly affecting the quoted price. It should be noted that the liquidation of a position in an OTC security may not even be possible within a reasonable period of time.
Dependable information regarding issuers of OTC securities, their prospects, or the risks associated with the business of any particular issuer or an investment in the issuer’s securities may not be available. For this reason, it may be difficult to properly value an investment in an OTC security or accurately determine the risks involved with investing in such a security. For more information about investing in microcap securities, please read the content on the SEC’s website, including the SEC’s investor publication titled “Microcap Stock: A Guide for Investors” available at https://www.sec.gov/investor/pubs/microcapstock.htm
Issuers of OTC securities quoted on the OTC Link system are not required to provide any kind of information to investors. While many issuers register OTC securities with the Securities and Exchange Commission (SEC) and regularly provide reports to investors in connection with such registration, they are not required to continue such registration or regularly provide such reports because their securities are quoted on OTC Link. Securities may continue to be quoted on the OTC Link system if issuers are delinquent in their reporting obligation to the SEC or other federal or state regulatory agencies. Quotation of a security on the OTC Link system or the Yellow Sheets does not in itself create any ongoing filing or reporting obligations with the SEC for any issuer. In fact, issuers may not even be aware that their securities are quoted on the OTC Link system.
Third-Party Content
The PharmaStocksToday website may contain Third-Party Content articles and other content submitted by third parties, including articles submitted through the PharmaStocksToday Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of PharmaStocksToday or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and PharmaStocksToday does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by PharmaStocksToday providing you with this internet portal that makes accessible to you the ability to view third-party content through the PharmaStocksToday site, PharmaStocksToday does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. PharmaStocksToday expressly disclaims liability relating to such third-party content. PharmaStocksToday and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, PharmaStocksToday reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://PharmaStocksTodayreport.com/disclaimer.
The disclaimers on the PharmaStocksToday Holdings LLC website applicable to all content provided by PharmaStocksToday, wherever published or re-published are at: https://PharmaStocksToday.com/disclaimer.
Client Indemnification
Recognizing that transactions of the type contemplated in an engagement sometimes result in litigation and that the role of PharmaStocksToday is public relations advisory and to offer a communications portal, the company or person who pays for the services offered by PharmaStocksToday agrees to advance costs and fees to, and indemnify and hold harmless PharmaStocksToday and its members and affiliates and their irrespective members, officers, directors, agents and controlling persons within the meaning of Section 15 of the Securities Act of 1933, as amended and Section 20(a) of the Securities Exchange Act (“Indemnified Parties”) and against any and all loss, charge, claim, damage, expense and liability whatsoever, including, but not limited to, all attorneys’ fees and expenses (hereinafter a “Claim” or “Claims”), related to or arising in any manner out of, based upon, or in connection with (i) any untrue statement or alleged untrue statement of a material fact made by the Company or any omission or alleged omission of the Company to state a material fact required to be stated therein or necessary to make the statements therein not misleading or (ii) any transaction, proposal or any other matter (items (i) and (ii) being hereinafter referred to as a “Matter” or “Matters”) contemplated by the engagement of PharmaStocksToday hereunder, and will promptly advance fees to the Indemnified Parties in the amount of three times the face amount of any written agreement between the Company and any of the Indemnified Parties and reimburse the Indemnified Parties for all expenses (including all fees and expenses of legal counsel incurred by PharmaStocksToday and the Indemnified Parties) as incurred in connection with the investigation of, preparation for or defence of any pending or threatened Claim related to or arising in any manner out of any Matter contemplated by the engagement of PharmaStocksToday hereunder, or any action or proceeding arising therefrom (collectively, “Proceedings”), regardless of whether such Indemnified Party is a formal party to any such Proceeding. Notwithstanding the foregoing, the Company shall not be liable in respect of any Claims that a court of competent jurisdiction has judicially determined by final judgment (and the time to appeal has expired or the last right of appeal has been denied) which resulted solely or in part from the gross negligence or wilful misconduct of an Indemnified Party or the violation of any securities laws or regulations by an Indemnified Party. The Company further agrees that it will not, without the prior written consent of PharmaStocksToday settle compromise or consent to the entry of any judgment in any pending or threatened proceeding in respect of which PharmaStocksToday and any Indemnified Party may seek indemnification hereunder (regardless of whether PharmaStocksToday or any Indemnified Party is an actual or potential party to such Proceeding), unless such settlement, compromise or consent includes an unconditional release of PharmaStocksToday and each other Indemnified Party hereunder from all liability arising out of such proceeding.
In order to provide for just and equitable contribution in any case in which (i) an Indemnified Party is entitled to indemnification pursuant to an Engagement Agreement but it is judicially determined by the entry of a final judgment decree by a court of competent jurisdiction and the time to appeal has expired or the last right of appeal has been denied) that such indemnification may not be enforced in such case, or (ii) contribution may be required by the Company in circumstances for which an Indemnified party is otherwise entitled to indemnification under the Agreement, then, and in each such case, the Company shall contribute to the aggregate losses, Claims, damages and/or liabilities in an amount equal to the amount for which indemnification was held unavailable. Notwithstanding the foregoing, PharmaStocksToday shall not be obligated to contribute any amount hereunder that exceeds the amount of fees previously received by PharmaStocksToday pursuant to an Agreement.
The Company further agrees that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with PharmaStocksToday’s engagement hereunder except for Claims that a court of competent jurisdiction shall have determined by final judgment (and the time to appeal has expired or the last right of appeal has been denied) resulted solely or in part from the gross negligence or wilful misconduct of such Indemnified Party or the violation of any securities laws or regulations by an Indemnified Party. The indemnity, re imbursement and contribution obligations of the Company set forth herein shall be in addition to any liability which the Company may otherwise have and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Company or an Indemnified Party.
The indemnity, reimbursement and contribution provisions set forth herein shall remain operative and in full force and effect regardless of (i) any withdrawal, termination or consummation of or failure to initiate or consummate any Matter referred to herein, (ii) any investigation made by or on behalf of any party hereto or any person controlling (within the meaning of Section 15 of the Securities act of 1933 as amended, or Section 20 of the Securities Exchange Act of 1934, as amended) any party hereto, (iii) any termination or the completion or expiration of an Engagement Agreement with PharmaStocksToday and (iv) regardless of whether PharmaStocksToday shall or shall not be called upon to render any public relations advice, whether formal or informal, in the course of such engagement.
Unless otherwise defined, capitalized terms used herein shall have the meaning ascribed to them in the Agreement.
Compensation Disclosure
The PharmaStocksToday website provides readers with information regarding publicly traded companies that have retained PharmaStocksToday to provide advertising branding, marketing, news syndication and public relations services on their behalf. PharmaStocksToday receives compensation from the companies in the form of cash and/or securities in the companies. Such compensation, especially compensation in the form of securities, may create an actual or potential conflict of interest. In addition, to the extent that parties, including the companies discussed, investors or others, further disseminate content or other statements provided by PharmaStocksToday, such parties operate outside of PharmaStocksToday’s control and such further dissemination is without the permission and authority of PharmaStocksToday. Such further dissemination may not be accompanied by appropriate disclaimers or other disclosures, and PharmaStocksToday assumes no responsibility for and expressly disclaims responsibility for any such statements, omissions or dissemination.
Because PharmaStocksToday receives compensation for disseminating information, we may have a conflict of interest in terms of disseminating negative information about the companies that retain us. Readers should consider this in reaching their independent decision as to how to use the information contained in the PharmaStocksToday website.
It is the practice of PharmaStocksToday to sell all securities received as compensation upon the expiration of the applicable holding period as set forth generally in Rule 144 under the Securities Act of 1933 (Rule 144), notwithstanding the fact that PharmaStocksToday may be advertising or distributing materials on such securities and their issuers at the time of the sale of such securities. More generally, PharmaStocksToday may sell any securities that it holds at any time that it legally may do so, as it deems appropriate.
In addition, writers and editors who provide or review content contained on PharmaStocksToday’s website may buy, sell or maintain positions in securities of the companies discussed on PharmaStocksToday’s website. Such trading, which necessarily reflects an individual’s personal resources and financial condition, may be inconsistent with statements on PharmaStocksToday website. PharmaStocksToday assumes no responsibility for and expressly disclaims responsibility for any statements or omissions about compensation to all writers and editors who provide or review content.
GDPR (Updated May 25, 2018)
The aim of the GDPR is to protect natural persons (EU/EEA Citizens) in relation to the processing of their personal data. The regulation applies to those within the EU/EEA which may hold such data, but also to those outside the EU/EEA which may offer goods or services to natural persons within that area, or send personal data to organization’s within the EU/EEA, or send personal data to recipients within the EU/EEA. IRP Holdings Corporation (IRPub), a US Based company, may offer good or services to natural persons of the EU/EEA from time to time via its websites as it is possible for these natural persons to find and visit our websites, therefore certain principles and rights exist for these natural persons that IRPub takes into consideration. As Defined in Article 4 (6), IRPub is to be considered a Data Controller. A Data Controller has certain obligations to natural persons (EU/EEA Citizens) when processing and storing your Personal data. Privacy Notice Data Controller obligations:
-Data must be available to the data subject.
-Describe what data will be collected and for what purposes.
-Detail any recipients who will receive the data, including if will be transferred outside EEA, and how data will be protected with onward transfer.
-If any legitimate interests exist in collecting and/or processing the data.
-Describe data retention and/or storage periods, or the criteria used to determine retention periods.
-Describe data subject rights, and how a data subject can exercise his/her rights.
-Details around any uses of automated decision-making.
Personal Data Collection Processing of your EU/EEA personal data may only apply under certain conditions, such as receiving your express consent or where processing is a necessary consequence of the establishment, exercise or defense of legal claims, or wherever courts are acting in their judicial capacity. IRPub has updated its privacy policies to notify EU/EEA citizens of their rights and also to be transparent where applicable of what information IRPub collects and how we process data of EU/EEA citizen’s personal data. IRPub DOES NOT collect what is to be considered sensitive personal data as some of the examples of such data include: race, ethnic background, religious/political affiliations and health and medical information about a data subject. IRPub DOES collect certain personal data in order for IRPub to provide its products and services to EU/EEA citizens upon receiving express consent. This personal data may include one or more of the following data attributes, dependent upon the submission form and data attributes filled out by the EU/EEA citizen:
-First Name
-Last Name
-Email Address
-Address
-Phone Number
In addition, before receiving express consent, there will be transparent and plain language that states IRPub may use this information for marketing purposes. Marketing is defined as sending internal and 3rd party offers that may be of interest to the EU/EEA citizen. Methods of communicating these offers include email, text, and phone. EU/EEA citizens have the right to opt out at any time by following the opt out instructions included in the marketing materials or by contacting us at admin@PharmaStocksToday.com. Please see the section Right of the EU/EEA Data Subject for more information below. IRPub DOES collect the following data upon visiting our website(s) which Include
-IP Address
-Metadata (browser version, device name, etc.)
-Cookie Data (expiring no more than 30 days)
The purpose of this data is to enhance user experience, and allows us to view visitors geo location, time on site, what device the user used to access our site, what browser version so we can better format and properly display pages to enhance viewing. Cookies may be used to remember settings or preferences from visitors or to not display the same advertisement or tailor or track advertisements. EU/EEA citizens will have the right to request cookie deletion and IRPub will work on those requests to the best of our ability. All requests can be sent to admin@PharmaStocksToday.com. Rights of the EU/EEA Data Subject EU/EEA citizens have rights to transparency, access, updating, restrict processing and which may also include to be forgotten. Below is a summary of the rights which the data subject has, including the right to request information. Under the GDPR what does this mean to you? As owners of your data, you are granted rights and data controllers who process and/or store your information, are required under GDPR to comply with your data requests. IRPub will respond to all requests in a reasonable time frame and in a courteous manner. IRPub will also store data no longer than necessarily needed as part of its data minimization practices:
Right to Access (Article 15): You have the right to request a copy of your personal data that IRPub has collected on you. Please send requests to admin@PharmaStocksToday.com. We will comply with this request in a timely manner to not be more than 30 days.
Right to Rectification (Article 16): You have the right to change inaccurate information of the data we have on you. For example, if you have a different email address or there is a typo or misspelling in your name you can send IRPub a request to update this information. Please send all update requests to admin@PharmaStocksToday.com. We will comply with this request in a timely manner to not be more than 30 days.
Right to Erasure (Article 17): You have the right to request to delete your data. You may request for IRPub to delete all existing personal data. You may also with to withdraw consent to not receive any future communications from IRPub. We will honor these requests in a timely manner not to exceed more than 30 days. Please send Right to Erasure requests to admin@PharmaStocksToday.com.
Right to Restriction of Processing (Article 18) You may request that IRPub stops using tracking data. Examples of tracking or behavior based tracking may include impressions, site visits, website clicks, and what pages you have visited and the time and duration on those pages. Please send Rights to Restrictions requests
Right to Data Portability (Article 20): In some cases, you may have the right to request that we move your data or transfer your data to another provider. Please send Right to Data Portability requests to admin@PharmaStocksToday.com.
Data Security
IRPub takes data security and the protection of a data subject’s information very seriously. Please see our Data Protection Policies for more information.
Data Breach of Data Subject
In case of a data Breach IRPub will inform such a breach occurred to a supervisory authority within 72 hours of the breach, if high risk impact is likely to data subjects.
If appropriate IRPub will give notice to the Data Subject
